- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.07. | INVO Bioscience, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 20.06. | INVO Bioscience, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 21.05. | INVO Bioscience files for $100M mixed shelf | 2 | Seeking Alpha | ||
| 16.05. | INVO BioScience reports Q1 results | 1 | Seeking Alpha | ||
| 15.05. | INVO Bioscience, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.05. | Peering Into INVO Bioscience's Recent Short Interest | 1 | Benzinga.com | ||
| 06.05. | INVO Bioscience, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.04. | INVO Bioscience, Inc. - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 23.04. | Bio-Path Holdings, Sunshine Biopharma, INVO Bioscience among healthcare movers | 4 | Seeking Alpha | ||
| 19.04. | INVO Bioscience, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 17.04. | INVO Bioscience, Inc. - 10-K/A, Annual Report | 4 | SEC Filings | ||
| 17.04. | Why Invo BioScience Stock Is Soaring Today | 9 | Benzinga.com | ||
| 17.04. | Why Is Invo Bioscience (INVO) Stock Up 85% Today? | 14 | InvestorPlace | ||
| 17.04. | Pre-market Movers: INVO Bioscience, iLearningEngines, Vanda Pharmaceuticals, CXApp, Chromocell Therapeutics | 431 | AFX News | LOWELL (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.45 A.M. ET).In the Green INVO Bioscience, Inc. (INVO) is up over 73% at $1.35.
Vanda... ► Artikel lesen | |
| 17.04. | Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket | 4 | Benzinga.com | ||
| 16.04. | INVO BioScience reports Q4 results | 4 | Seeking Alpha | ||
| 16.04. | INVO Bioscience: INVO Reports Fourth Quarter and Full Year 2023 Financial Results | 185 | GlobeNewswire (Europe) | SARASOTA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment... ► Artikel lesen | |
| 16.04. | INVO Bioscience, Inc. - 10-K, Annual Report | 1 | SEC Filings | ||
| 11.04. | INVO Bioscience, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.04. | INVO Bioscience, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings |
Seite:
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INTUITIVE SURGICAL | 407,00 | +0,12 % | Intuitive Surgical: AKTIONÄR-Tipp außer Rand und Band - das ist der Grund | Ende März 2023 hatte DER AKTIONÄR zum Einstieg beim amerikanischen Gesundheitskonzern Intuitive Surgical geraten; Anleger, die der Empfehlung gefolgt sind, liegen 75 Prozent vorne. Am Donnerstag nach... ► Artikel lesen | |
| ROKU | 54,18 | -0,39 % | Why Roku Stock Was Slipping This Week | ||
| ATOSSA THERAPEUTICS | 1,266 | -6,22 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Completes Enrollment of 80mg Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast Cancer | SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company") today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Lupin Divests U.S. Commercial Women's Health Specialty Business To Evofem Biosciences | NEW DELHI (dpa-AFX) - Pharma major Lupin Ltd. announced Monday that it has divested its U.S. Commercial Women's Health Specialty Business to Evofem Biosciences, Inc. (EVFM), a U.S. biopharmaceutical... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,060 | +2,91 % | Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results | SALT LAKE CITY, May 9, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| QUIDELORTHO | 35,200 | -0,56 % | S&P Dow Jones Indices: Avantor Set to Join S&P MidCap 400; QuidelOrtho & Schneider National to Join S&P SmallCap 600 | NEW YORK, July 23, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600:
Avantor Inc. (NYSE:AVTR) will replace QuidelOrtho Corp.... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 1,588 | +1,15 % | Tempest Therapeutics files for mixed shelf offering of up to $300M | ||
| VERU | 0,843 | -3,33 % | Veru Inc.: Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical Program | --Phase 2b clinical study of enobosarm in combination with semaglutide (Wegovy®*) for high quality weight loss is actively enrolling-- --Company assembles esteemed high quality weight loss Scientific... ► Artikel lesen | |
| CENTENE | 65,00 | -3,46 % | ROUNDUP: Centene Backs FY24 Earnings View, Lifts Revenue Forecast | WASHINGTON (dpa-AFX) - Healthcare enterprise Centene Corp. (CNC), while reporting higher second-quarter results, on Friday maintained its fiscal 2024 earnings view, but lifted revenue forecast.In... ► Artikel lesen | |
| IMAGIN MEDICAL | 0,001 | 0,00 % | XFRA DPD3: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILIMAGIN MEDICAL INC.... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 13,780 | +1,03 % | Perspective Therapeutics, Inc.: Perspective Therapeutics to Provide Business Highlights and Report Second Quarter 2024 Financial Results | ||
| LANTHEUS | 104,00 | +0,14 % | Lantheus Holdings, Inc.: Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer's Disease | BEDFORD, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight... ► Artikel lesen | |
| AMN HEALTHCARE SERVICES | 57,50 | +2,68 % | AMN Healthcare Services Inc. Q1 Profit Decreases, But Beats Estimates | WASHINGTON (dpa-AFX) - AMN Healthcare Services Inc. (AMN) revealed a profit for first quarter that decreased from the same period last year but beat the Street estimates.The company's bottom... ► Artikel lesen | |
| OMNICELL | 26,800 | -0,74 % | Omnicell Announces First Quarter 2024 Results | FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (NASDAQ:OMCL) ("Omnicell," "we," "our," "us," "management," or the "Company"), a leader in transforming the pharmacy care delivery model, today... ► Artikel lesen | |
| TEMPUS AI | 41,920 | +4,75 % | wO Börsenlounge: Eli Lilly | Tempus AI | BP & Rechenzentrenperle aus Schweden | Rechenzentren schießen wie Pilze aus dem Boden. Die Nachfrage ist groß, da KI-Modelle schließlich richtig viel Rechenpower brauchen. Die üblichen Verdächtigen sind wieder angesprungen. Eine Perle aus... ► Artikel lesen |
Das Unternehmen INVO BIOSCIENCE INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +11,26 % bei einem Aktienkurs von 0,820 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INVO BIOSCIENCE INC finden Sie auf Wallstreet Online.
